Monday, August 8, 2022
Home Merck to launch antiviral pill, Molnupiravir, for Covid Merck to launch antiviral pill, Molnupiravir, for Covid

Merck to launch antiviral pill, Molnupiravir, for Covid

Merck, pill, Molnupiravir, Covid, vaccines, FDA, benefits, anti-vaxers, vaccinated, unvaccinated, Dr Robert Schafer, Jeff Zients,

Clinical trials on a new antiviral drug, Molnupiravir, from Merck were stopped early because the results were so convincing and represent a game-changer for many people worldwide who cannot have, or don’t want, the current vaccines.